The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...
Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum ...
The PBM plans to stop requiring coverage authorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...
Optum Rx — which includes the pharmacy benefit manager of health care conglomerate UnitedHealth Group — is dropping annual ...
Optum Rx has eliminated prior authorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...
UnitedHealth Group (NYSE:UNH) announced Wednesday its pharmacy benefit manager, Optum Rx, would eliminate up to 25% of reauthorizations, easing patients’ access to multiple medications when their ...
UnitedHealth Group’s pharmacy benefit manager OptumRx plans to cut up to 25% of its medication reauthorizations. OptumRx will ...
UnitedHealth Group Inc.’s pharmacy benefit manager, Optum Rx, will ease renewal requirements for certain long-term ...
Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal ...
UnitedHealth Group's pharmacy business, Optum Rx, said it is eliminating up to 25% of reauthorizations for prescription drugs to simplify access for consumers.
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Optum Rx, the pharmacy benefit manager under UnitedHealth Group, is set to eliminate prior authorization requirements for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results